390 related articles for article (PubMed ID: 31898237)
1. Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway.
Zhou H; Lu J; Yang CY; Sun Y; Wang S
Adv Exp Med Biol; 2020; 1217():349-362. PubMed ID: 31898237
[TBL] [Abstract][Full Text] [Related]
2. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer.
Li L; Kang J; Zhang W; Cai L; Wang S; Liang Y; Jiang Y; Liu X; Zhang Y; Ruan H; Chen G; Wang M; Jia L
EBioMedicine; 2019 Jul; 45():81-91. PubMed ID: 31208947
[TBL] [Abstract][Full Text] [Related]
3. Targeting neddylation E2s: a novel therapeutic strategy in cancer.
Zheng YC; Guo YJ; Wang B; Wang C; Mamun MAA; Gao Y; Liu HM
J Hematol Oncol; 2021 Apr; 14(1):57. PubMed ID: 33827629
[TBL] [Abstract][Full Text] [Related]
4. SENP8 limits aberrant neddylation of NEDD8 pathway components to promote cullin-RING ubiquitin ligase function.
Coleman KE; Békés M; Chapman JR; Crist SB; Jones MJ; Ueberheide BM; Huang TT
Elife; 2017 May; 6():. PubMed ID: 28475037
[TBL] [Abstract][Full Text] [Related]
5. High-Affinity Peptidomimetic Inhibitors of the DCN1-UBC12 Protein-Protein Interaction.
Zhou H; Zhou W; Zhou B; Liu L; Chern TR; Chinnaswamy K; Lu J; Bernard D; Yang CY; Li S; Wang M; Stuckey J; Sun Y; Wang S
J Med Chem; 2018 Mar; 61(5):1934-1950. PubMed ID: 29438612
[TBL] [Abstract][Full Text] [Related]
6. Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.
Zhao Y; Morgan MA; Sun Y
Antioxid Redox Signal; 2014 Dec; 21(17):2383-400. PubMed ID: 24410571
[TBL] [Abstract][Full Text] [Related]
7. A potent small-molecule inhibitor of the DCN1-UBC12 interaction that selectively blocks cullin 3 neddylation.
Zhou H; Lu J; Liu L; Bernard D; Yang CY; Fernandez-Salas E; Chinnaswamy K; Layton S; Stuckey J; Yu Q; Zhou W; Pan Z; Sun Y; Wang S
Nat Commun; 2017 Oct; 8(1):1150. PubMed ID: 29074978
[TBL] [Abstract][Full Text] [Related]
8. UBE2M Is a Stress-Inducible Dual E2 for Neddylation and Ubiquitylation that Promotes Targeted Degradation of UBE2F.
Zhou W; Xu J; Tan M; Li H; Li H; Wei W; Sun Y
Mol Cell; 2018 Jun; 70(6):1008-1024.e6. PubMed ID: 29932898
[TBL] [Abstract][Full Text] [Related]
9. Development of Highly Potent, Selective, and Cellular Active Triazolo[1,5- a]pyrimidine-Based Inhibitors Targeting the DCN1-UBC12 Protein-Protein Interaction.
Wang S; Zhao L; Shi XJ; Ding L; Yang L; Wang ZZ; Shen D; Tang K; Li XJ; Mamun M; Li H; Yu B; Zheng YC; Wang S; Liu HM
J Med Chem; 2019 Mar; 62(5):2772-2797. PubMed ID: 30803229
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of cullin 3 neddylation through covalent targeting DCN1 protects mice from acetaminophen-induced liver toxicity.
Zhou H; Lu J; Chinnaswamy K; Stuckey JA; Liu L; McEachern D; Yang CY; Bernard D; Shen H; Rui L; Sun Y; Wang S
Nat Commun; 2021 May; 12(1):2621. PubMed ID: 33976147
[TBL] [Abstract][Full Text] [Related]
11. Dcn1 functions as a scaffold-type E3 ligase for cullin neddylation.
Kurz T; Chou YC; Willems AR; Meyer-Schaller N; Hecht ML; Tyers M; Peter M; Sicheri F
Mol Cell; 2008 Jan; 29(1):23-35. PubMed ID: 18206966
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Novel Pyrazolo-pyridone DCN1 Inhibitors Controlling Cullin Neddylation.
Kim HS; Hammill JT; Scott DC; Chen Y; Min J; Rector J; Singh B; Schulman BA; Guy RK
J Med Chem; 2019 Sep; 62(18):8429-8442. PubMed ID: 31465221
[TBL] [Abstract][Full Text] [Related]
13. Introduction.
Sun Y
Adv Exp Med Biol; 2020; 1217():1-8. PubMed ID: 31898218
[TBL] [Abstract][Full Text] [Related]
14. Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M Interaction.
Zhou W; Ma L; Ding L; Guo Q; He Z; Yang J; Qiao H; Li L; Yang J; Yu S; Zhao L; Wang S; Liu HM; Suo Z; Zhao W
J Med Chem; 2019 Jun; 62(11):5382-5403. PubMed ID: 31157974
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical Inhibition of Neddylation as Promising Treatments for Various Cancers.
Yin L; Xue Y; Shang Q; Zhu H; Liu M; Liu Y; Hu Q
Curr Top Med Chem; 2019; 19(12):1059-1069. PubMed ID: 30854973
[TBL] [Abstract][Full Text] [Related]
16. Nedd8-Activating Enzyme Is a Druggable Host Dependency Factor of Human and Mouse Cytomegalovirus.
Flores-Martínez YA; Le-Trilling VTK; Trilling M
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452475
[TBL] [Abstract][Full Text] [Related]
17. Neddylation-CRLs regulate the functions of Treg immune cells.
Wu D; Sun Y
Bioessays; 2023 Apr; 45(4):e2200222. PubMed ID: 36709423
[TBL] [Abstract][Full Text] [Related]
18. Improvement of Oral Bioavailability of Pyrazolo-Pyridone Inhibitors of the Interaction of DCN1/2 and UBE2M.
Kim HS; Hammill JT; Scott DC; Chen Y; Rice AL; Pistel W; Singh B; Schulman BA; Guy RK
J Med Chem; 2021 May; 64(9):5850-5862. PubMed ID: 33945681
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Potent and Selective 2-(Benzylthio)pyrimidine-based DCN1-UBC12 Inhibitors for Anticardiac Fibrotic Effects.
He ZX; An Q; Wei B; Zhou WJ; Wei BF; Gong YP; Zhang X; Gao G; Dong GJ; Huo JL; Zhang XH; Yang FF; Liu HM; Ma LY; Zhao W
J Med Chem; 2022 Jan; 65(1):163-190. PubMed ID: 34939411
[TBL] [Abstract][Full Text] [Related]
20. Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells.
Wang Y; Luo Z; Pan Y; Wang W; Zhou X; Jeong LS; Chu Y; Liu J; Jia L
Cancer Biol Ther; 2015; 16(3):420-9. PubMed ID: 25782162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
